{
    "laboratory_examinations": [
        {
            "procedure_name": "Complete Blood Count (CBC)",
            "date": "Not specified",
            "findings": {
                "hematocrit": "38.4% (low; reference range: 41.0 to 53.0)",
                "hemoglobin": "13.4 g/dL (low; reference range: 13.5 to 17.5)",
                "white_cell_count": "Normal",
                "platelet_count": "Normal"
            },
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Electrolytes, Glucose, Protein, Albumin, Globulin, and Bilirubin tests",
            "date": "Not specified",
            "findings": "All results were normal.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT-guided Fine-Needle Aspiration",
            "date": "Not specified",
            "findings": "Cytologic examination revealed poorly differentiated adenocarcinoma.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Epidermal Growth Factor Receptor (EGFR) Sequencing",
            "date": "Not specified",
            "findings": "Frameshift deletion in exon 19.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT Scan",
            "date": "Nine months after right lower lobectomy",
            "findings": "New nodule 1.3 cm in the middle lobe of the right lung and multiple bilateral lung nodules (consistent with recurrent NSCLC).",
            "changes_over_time": "Disease in the lung was stable after chemotherapy, but new metastatic disease developed nine months later."
        },
        {
            "procedure_name": "Repeat CT and Genetic Testing",
            "date": "Not specified",
            "findings": {
                "EGFR_mutation": "E746_A750del and T790M mutation (conferring resistance to available tyrosine kinase inhibitors).",
                "tumor_suppressor_gene": "TP53 mutation."
            },
            "changes_over_time": "Resistance mutation T790M developed at the time of acquired drug resistance."
        }
    ]
}